Syros Pharmaceuticals (NASDAQ:SYRS) Stock Rating Upgraded by BidaskClub
Syros Pharmaceuticals (NASDAQ:SYRS) was upgraded by stock analysts at BidaskClub from a “sell” rating to a “hold” rating in a report released on Thursday, BidAskClub … Read more